Sun Pharma secures marketing rights for stroke drug Tyvalzi from Pharmazz
Sun Pharmaceutical Industries Limited has entered into a license agreement with U.S.-based biopharmaceutical company Pharmazz Inc. for the commercialization of the first-in-class innovative drug, Tyvalzi ... Read More
AstraZeneca gets BRILINTA FDA approval for reducing risk of stroke in acute ischemic stroke or high-risk transient ischemic attack
BRILINTA FDA approval : AstraZeneca has bagged approval for BRILINTA (ticagrelor) from the US Food and Drug Administration for its use in reducing the risk ... Read More
Seneca Biopharma completes cell manufacturing facility in Suzhou, China
Seneca Biopharma (formerly Neuralstem), a biopharma company engaged in developing treatments for diseases of high unmet medical need, has completed construction on its new cell ... Read More
Oral Contraceptives may increase risk of ischemic strokes in women
Oral Contraceptives, commonly known as birth control pills are known to block blood flow to the brain which may result in ischemic strokes. However, Ischemic ... Read More